TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11699052

Group type: EXPERIMENTAL
Intervention: Obese women
Number of subjects: 64

Group type: COMPARATOR
Intervention: Normal-weight subjects
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: All groups (obese and normal-weight)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Postprandial state
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Plasma HDL-C concentration
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Postprandial efflux
Number of subjects: 64
Study: 9021439

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg tirilazad mesylate every 6 hours for 29 doses (6.0 mg/kg/day for 7 days)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 3.0 mg/kg tirilazad mesylate every 6 hours for 29 doses (12.0 mg/kg/day for 7 days)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 4.0 mg/kg tirilazad mesylate every 6 hours for 29 doses (16.0 mg/kg/day for 7 days)
Number of subjects: 18
Study: 7950115

Group type: EXPERIMENTAL
Intervention: Monofocal IOL (Pharmacia 720A)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Multifocal IOL (3M 825X)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Healthy phakic eyes (Control Group)
Number of subjects: 84
Study: 2467136

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 1875538

Group type: EXPERIMENTAL
Intervention: ONO 3708 (2.5 micrograms.kg‐1.min‐1 given with continuous infusion)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 1087137

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate once per month with citrovorum rescue for 3 months
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Immunization with a homogenate of Freund's complete adjuvant and soluble antigen derived from allogeneic lung cancer cells for 3 months
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination of methotrexate and immunization monthly for 3 months
Number of subjects: 33

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 33

Group type: COMPARATOR
Intervention: Immunization
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination immunochemotherapy
Number of subjects: 33
Study: 30612246

Group type: EXPERIMENTAL
Intervention: ART restorations
Number of subjects: 154

Group type: COMPARATOR
Intervention: Composite resin restorations
Number of subjects: 154
Study: 27140481

Group type: EXPERIMENTAL
Intervention: Sport-specific drill training (MT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-Intensity Training (MT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sport-specific drill training alone (DT)
Number of subjects: 20
Study: 27979834

Group type: EXPERIMENTAL
Intervention: Ciclosporin 2.5 mg/kg as an intravenous injection after anaesthesia induction but before start of surgery
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo as an intravenous injection after anaesthesia induction but before start of surgery
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ciclosporin 2.5 mg/kg
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 24332586

Group type: EXPERIMENTAL
Intervention: Tongue strengthening programme paired with traditional exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional exercises alone
Number of subjects: 0
Study: 21331635

Group type: EXPERIMENTAL
Intervention: Ozone treatment (60 s)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no ozone treatment)
Number of subjects: 12
Study: 19602718

Group type: EXPERIMENTAL
Intervention: TETA 100 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TETA 300 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TETA 600 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TETA 1800 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17469886

Group type: EXPERIMENTAL
Intervention: Mailed feedback intervention
Number of subjects: 1488

Group type: COMPARATOR
Intervention: Assessment-only control
Number of subjects: 1488
Study: 15280678

Group type: EXPERIMENTAL
Intervention: Single-bolus antithymocyte globulin (ATG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cyclosporine triple therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: T-cell IgM FCXM
Number of subjects: 0
Study: 12075256

Group type: EXPERIMENTAL
Intervention: 1.0 V
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.5 V
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 2.5 V
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0 V (with pacing thresholds of 0.5 V or less)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1.0 V (with pacing thresholds >0.5 V)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1.5 V and 2.5 V
Number of subjects: 12
Study: 10721408

Group type: EXPERIMENTAL
Intervention: Entonox only
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intravenous sedation
Number of subjects: 45
Study: 7605183

Group type: EXPERIMENTAL
Intervention: Prediction equation (EXP) derived from PRE group data
Number of subjects: 55

Group type: COMPARATOR
Intervention: Validation group (VAL)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Comparison to previously published equations for clockwise ACE
Number of subjects: 55
Study: 2195537

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Suction from the central bronchial system
Number of subjects: 29
Study: 96461

Group type: EXPERIMENTAL
Intervention: Ciclazindol (100 mg/day)
Number of subjects: 0
Study: 31840260

Group type: EXPERIMENTAL
Intervention: Web-based pediatric palliative care education
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 265
Study: 31397184

Group type: EXPERIMENTAL
Intervention: TIO/FORMfixed (18/12 µg once daily via Discair inhaler)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: TIO/FORMbid (tiotropium 18 µg by Handihaler + formoterol 12 µg twice daily by Aerolizer)
Number of subjects: 84

Group type: COMPARATOR
Intervention: TIOmono (tiotropium 18 µg by Handihaler)
Number of subjects: 84
Study: 28750854

Group type: EXPERIMENTAL
Intervention: DVC-LVS
Number of subjects: 228

Group type: COMPARATOR
Intervention: USAMRIID-LVS
Number of subjects: 228
Study: 25873721

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HI(I)T)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 24016282

Group type: COMPARATOR
Intervention: Conventional phototherapy (CP)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Light emitting diode phototherapy (LP)
Number of subjects: 58
Study: 21266932

Group type: EXPERIMENTAL
Intervention: Practice group (n = 15) - completed six additional sessions to practice a functional task (Grooved Pegboard)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n = 8) - no additional practice sessions
Number of subjects: 23
Study: 19181514

Group type: EXPERIMENTAL
Intervention: Spinal catheter anaesthesia with diamorphine 300 microg and 0.5% hyperbaric bupivacaine
Number of subjects: 34
Study: 17532101

Group type: EXPERIMENTAL
Intervention: PsA‐TT vaccine (Group 1)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Meningococcal Polysaccharide Vaccine A+C (Group 2)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Tetanus Toxoid Vaccine Adsorbed (Group 3)
Number of subjects: 74
Study: 14985695

Group type: EXPERIMENTAL
Intervention: Once-a-week 2800 microg folic acid supplement
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Daily 400 microg folic acid supplement
Number of subjects: 114

Group type: COMPARATOR
Intervention: Daily placebo
Number of subjects: 114
Study: 15321547

Group type: EXPERIMENTAL
Intervention: Oxford position (group O)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Right lateral to supine wedged position (group R)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sitting to supine wedged position (group S)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 90
Study: 9579235

Group type: EXPERIMENTAL
Intervention: CRH(1‐41)/GHRH‐(1‐29)‐NH2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ACTH/GHRH‐(1‐29)‐NH2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: hydrocortisone/GHRH‐(1‐29)‐NH2
Number of subjects: 6

Group type: COMPARATOR
Intervention: saline/GHRH‐(1‐29)‐NH2
Number of subjects: 6
Study: 7893272

Group type: EXPERIMENTAL
Intervention: Legalon
Number of subjects: 7

Group type: COMPARATOR
Intervention: Other silymarin preparations
Number of subjects: 7
Study: 2491140

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 824953

Group type: EXPERIMENTAL
Intervention: Prophylactic cephalosporins
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 30693096

Group type: EXPERIMENTAL
Intervention: Smoking cessation treatment alongside usual IAPT care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual IAPT treatment alone
Number of subjects: 0
Study: 29927785

Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid (ZOL) 5 mg annually for 2 years
Number of subjects: 87

Group type: COMPARATOR
Intervention: Switching from tenofovir disoproxil fumarate (TDF) to another active antiretroviral drug
Number of subjects: 87
Study: 27239927

Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg + ASA 300 mg (Subgroup 2)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: ASA 300 mg + Ticagrelor 90 mg twice daily (Subgroup 3)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg + ASA 300 mg (Subgroup 1)
Number of subjects: 124
Study: 25336097

Group type: EXPERIMENTAL
Intervention: Nasal saline irrigation (isotonic and hypertonic solutions)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal aspiration with isotonic saline solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isotonic and hypertonic saline solutions
Number of subjects: 0
Study: 23150927

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 mcg)
Number of subjects: 860

Group type: COMPARATOR
Intervention: Standard surgical care
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol and Standard surgical care
Number of subjects: 860
Study: 20214777

Group type: EXPERIMENTAL
Intervention: Web-based self-help intervention based on Cognitive Behavioural Therapy (CBT)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Information-control condition
Number of subjects: 260
Study: 17709365

Group type: EXPERIMENTAL
Intervention: Conventional coronary artery bypass grafting (Group A)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Off-pump surgery (Group B)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting with modified, rheoparin coated cardiopulmonary bypass (Group C)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Group A (Conventional coronary artery bypass grafting)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Group B and C (Off-pump surgery and modified cardiopulmonary bypass)
Number of subjects: 65
Study: 16330721

Group type: EXPERIMENTAL
Intervention: Telephone-based care management intervention (n = 116)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Usual care (n = 75)
Number of subjects: 191
Study: 12006508

Group type: EXPERIMENTAL
Intervention: QS-21
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 26

Group type: COMPARATOR
Intervention: IFA
Number of subjects: 26
Study: 9667541

Group type: COMPARATOR
Intervention: Children's Lake Louise AMS Score (CLLS) assessed on day 4 after travel to 3488 m.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control days (1 and 2) measurements at home and day 3 travel without altitude change to 1615 m.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Adults accompanying the children completed the Lake Louise Scoring System on days 3 and 4.
Number of subjects: 23
Study: 8617554

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg daily for 5 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Metronidazole 400 mg daily for 5 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Metronidazole 7.5 mg/Kg thrice daily for 5 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Metronidazole therapy
Number of subjects: 64
Study: 2765377

Group type: EXPERIMENTAL
Intervention: Tamoxifen (10 mg or 20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1009348

Group type: EXPERIMENTAL
Intervention: Elemental diet (Vivonex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30252507

Group type: EXPERIMENTAL
Intervention: Household and caregiving activities
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Occupational PA
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Light-intensity PA
Number of subjects: 251
Study: 28786722

Group type: EXPERIMENTAL
Intervention: Amoeba system with pattern‐based addressing and injected entropy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoeba system without specified features
Number of subjects: 0
Study: 26635296

Group type: EXPERIMENTAL
Intervention: Consensus messages about vaccine safety (90% of medical scientists agree vaccines are safe)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 206
Study: 23428963

Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Use of FAQs to support peer supporters
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Insights gained from FAQs
Number of subjects: 182
Study: 22028938

Group type: EXPERIMENTAL
Intervention: Killed whole-cell oral cholera vaccine (OCV)
Number of subjects: 66900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66900
Study: 18316547

Group type: EXPERIMENTAL
Intervention: Panitumumab (6 mg/kg every other week)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Panitumumab
Number of subjects: 463
Study: 16735582

Group type: EXPERIMENTAL
Intervention: Buffered platelet-rich plasma
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 20
Study: 12898174

Group type: EXPERIMENTAL
Intervention: Unenhanced helical computed tomography (UHCT)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Intravenous urography (IVU)
Number of subjects: 122
Study: 10724054

Group type: EXPERIMENTAL
Intervention: CAUTI (235 new cases during the study period)
Number of subjects: 1497

Group type: EXPERIMENTAL
Intervention: Subset of 1034 patients with CAUTI (89 with >103 colony-forming units/mL)
Number of subjects: 1497

Group type: EXPERIMENTAL
Intervention: CAUTI episodes studied (235 episodes)
Number of subjects: 1497
Study: 8754444

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (group A)
Number of subjects: 463

Group type: COMPARATOR
Intervention: No thrombolytic therapy (group B)
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy in patients with left ventricular dysfunction
Number of subjects: 463

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy in patients with symptom delay > 4 hours
Number of subjects: 463
Study: 8435695

Group type: EXPERIMENTAL
Intervention: Home based care (daily living programme)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Standard hospital care
Number of subjects: 189
Study: 3628243

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 60
Study: 28647136

Group type: EXPERIMENTAL
Intervention: CSP (Cold Snare Polypectomy)
Number of subjects: 358

Group type: COMPARATOR
Intervention: EMR (Endoscopic Mucosal Resection)
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Piecemeal resection
Number of subjects: 358

Group type: EXPERIMENTAL
Intervention: Both EMR and CSP
Number of subjects: 358
Study: 24467369

Group type: EXPERIMENTAL
Intervention: Aripiprazole (0, 2 or 10 mg/day/p.o.)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Smoking abstinence procedure
Number of subjects: 21
Study: 22236488

Group type: EXPERIMENTAL
Intervention: Disease management approach including systematic screening, treatment upon positive screening, monitoring, and intensified treatment in case of non-remission.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified in the abstract.
Number of subjects: 0
Study: 20132138

Group type: EXPERIMENTAL
Intervention: Internet-based physical activity intervention
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 18346028

Group type: EXPERIMENTAL
Intervention: Artesunate plus amodiaquine (ASAQ) - artesunate 4 mg/kg daily and amodiaquine 10 mg/kg daily for 3 days.
Number of subjects: 132

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) - 5-14 kg: one tablet; 15-24 kg: two tablets; 25-34 kg: three tablets, twice daily for 3 days.
Number of subjects: 132
Study: 16259789

Group type: EXPERIMENTAL
Intervention: 2 x 600 mg reduced glutathione per day
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2 x 50 mg alpha‐lipoic acid per day
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 2 x 100 mg N‐acetylcysteine per day
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard treatment (ST) based on WHO recommendations
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 37
Study: 12207629

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer (NEB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer with 25 g oral charcoal (NEBC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer (NEB) vs Nebulizer with charcoal (NEBC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI) vs Oral (ORAL)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nebulizer (NEB) vs Oral (ORAL)
Number of subjects: 12
Study: 10567754

Group type: EXPERIMENTAL
Intervention: C6 tetraplegia
Number of subjects: 69

Group type: COMPARATOR
Intervention: Paraplegia
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: C7 tetraplegia
Number of subjects: 69
Study: 7476326

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg/d for 12 months
Number of subjects: 18
Study: 2341935

Group type: EXPERIMENTAL
Intervention: Mandibular bone grafts (MBG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iliac crest bone (ICB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (MBG and ICB)
Number of subjects: 40
Study: 219269

Group type: EXPERIMENTAL
Intervention: Dianhydrogalactitol plus whole-brain irradiation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Whole-brain irradiation alone
Number of subjects: 42
Study: 31813599

Group type: EXPERIMENTAL
Intervention: Instrumentation with rotary files and irrigation with 2.5% sodium hypochlorite (NaOCl) and 17% ethylene diamine tetra acetic acid (EDTA)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Instrumentation with rotary files and irrigation with sterile saline
Number of subjects: 42

Group type: COMPARATOR
Intervention: No endodontic intervention
Number of subjects: 42
Study: 30522566

Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 300
Study: 28295198

Group type: EXPERIMENTAL
Intervention: Omalizumab treatment
Number of subjects: 0
Study: 25490913

Group type: COMPARATOR
Intervention: Cold pressor test (CPT)
Number of subjects: 93
Study: 23890351

Group type: EXPERIMENTAL
Intervention: 10 mg monacolins
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 21291335

Group type: EXPERIMENTAL
Intervention: Miglitol (50 mg) before meals
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acarbose (100 mg) before meals
Number of subjects: 10
Study: 19811594

Group type: EXPERIMENTAL
Intervention: Internal Quality Improvement (QI) activities in G1
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: External feedback in G2 (subgroup with QI activities)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group G3 (no intervention)
Number of subjects: 500
Study: 17120700

Group type: EXPERIMENTAL
Intervention: Conscious and unconscious aromatherapy and multimodal sensory activation
Number of subjects: 0
Study: 14990595

Group type: EXPERIMENTAL
Intervention: Sputum examination in patients with SARS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control samples from age matched controls
Number of subjects: 15
Study: 11374092

Group type: EXPERIMENTAL
Intervention: Bilateral deep brain stimulation (STN stimulation)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PD patients off stimulation
Number of subjects: 16
Study: 9404766

Group type: EXPERIMENTAL
Intervention: 8 mg/kg nebulized 2% lidocaine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4 mg/kg nebulized 2% lidocaine
Number of subjects: 20
Study: 8175498

Group type: EXPERIMENTAL
Intervention: Breathers (inspired from the loads through a J valve)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pullers (reciprocally stroked the plunger of a 2-liter syringe connected to the J valve)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Breathers with supplemental audio feedback
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Listeners receiving airflow feedback
Number of subjects: 48
Study: 3066965

Group type: EXPERIMENTAL
Intervention: Hypothiazide 25 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hypothiazide 50 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hypothiazide 100 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Oxodoline 50 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Oxodoline 100 mg
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Hypothiazide and Oxodoline
Number of subjects: 132
Study: 30349585

Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses and The Back Book
Number of subjects: 60

Group type: COMPARATOR
Intervention: The Back Book
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prefabricated foot orthoses
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Foot type
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 60